| Robert Avery, | |
|
2211 Lomas Blvd Ne Fl 1, Albuquerque, NM 87106-2719 | |
| (505) 272-2553 | |
| (505) 272-6297 |
| Full Name | Robert Avery |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 26 Years |
| Location | 2211 Lomas Blvd Ne Fl 1, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871509570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 2004-0321 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of New Mexico Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
Patients with high-risk, locally advanced rectal cancer could benefit from neoadjuvant chemotherapy before undergoing chemoradiotherapy, suggest the results of a pooled analysis.
Scientists have shown that early growth hormone supplementation in rats with growth hormone deficiency can prevent defects in memory developing later in adulthood. The study, published in the Journal of Endocrinology is the first to show that memory defects in adults as a result of growth hormone deficiency arising in childhood can be prevented by growth hormone treatment during adolescence.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.
Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.
› Verified 6 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
Patients with high-risk, locally advanced rectal cancer could benefit from neoadjuvant chemotherapy before undergoing chemoradiotherapy, suggest the results of a pooled analysis.
Scientists have shown that early growth hormone supplementation in rats with growth hormone deficiency can prevent defects in memory developing later in adulthood. The study, published in the Journal of Endocrinology is the first to show that memory defects in adults as a result of growth hormone deficiency arising in childhood can be prevented by growth hormone treatment during adolescence.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.
Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Avery, 933 Bradbury Dr Se, Suite 2222, Albuquerque, NM 87106-4374 Ph: (505) 272-3120 | Robert Avery, 2211 Lomas Blvd Ne Fl 1, Albuquerque, NM 87106-2719 Ph: (505) 272-2553 |
News Archive
Patients with high-risk, locally advanced rectal cancer could benefit from neoadjuvant chemotherapy before undergoing chemoradiotherapy, suggest the results of a pooled analysis.
Scientists have shown that early growth hormone supplementation in rats with growth hormone deficiency can prevent defects in memory developing later in adulthood. The study, published in the Journal of Endocrinology is the first to show that memory defects in adults as a result of growth hormone deficiency arising in childhood can be prevented by growth hormone treatment during adolescence.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.
Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.
› Verified 6 days ago
Rebecca Suzanne Leenheer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 303 Mulberry St Ne, Albuquerque, NM 87106 Phone: 505-243-9739 Fax: 505-842-0650 | |
Ana G Huaman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3901 Georgia St Ne Ste G-2, Albuquerque, NM 87110 Phone: 505-266-8200 Fax: 505-256-7565 | |
John E Graham, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5400 Gibson Blvd Se, Albuquerque, NM 87108 Phone: 505-262-3937 Fax: 505-262-7147 | |
Dr. Michael Scott Seligson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4343 Pan American Fwy Ne, Ste. 224, Albuquerque, NM 87107 Phone: 505-344-5400 Fax: 505-344-5404 | |
Charles Chiang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5757 Harper Dr Ne, Albuquerque, NM 87109 Phone: 505-888-5757 Fax: 505-865-0160 | |
Dr. Ian Abban Thompson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4411 The 25 Way Ne Ste 325, Albuquerque, NM 87109 Phone: 505-823-4411 Fax: 505-343-6085 | |
Robert K Rothberg, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5150 Journal Center Blvd Ne, Albuquerque, NM 87109 Phone: 505-262-3937 Fax: 505-262-3366 |